首页> 外文OA文献 >Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting

【2h】

Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting

机译：度他雄胺加坦索罗辛固定剂量联合一线治疗与坦索罗辛单药治疗良性前列腺增生：希腊医疗机构的预算影响分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Re: Dutasteride plus Tamsulosin Fixed-Dose Combination First-Line Therapy versus Tamsulosin Monotherapy in the Treatment of Benign Prostatic Hyperplasia: A Budget Impact Analysis in the Greek Healthcare Setting Editorial Comment [J] . Kashyap M., Belleville S., Mulsant B. H., The Journal of Urology . 2015,第5期

机译：Re：Cutasteride Plus Tamsulosin固定剂量组合第一线疗法与Tamsulosin单疗法治疗良性前列腺增生：在希腊医疗保健环境中的预算影响分析编辑评论
2. Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting [J] . Maria Geitona, Pinelopi Karabela, Ioannis A Katsoulis, BMC Urology . 2014,第1期

机译：度他雄胺加坦索罗辛固定剂量联合一线治疗与坦索罗辛单药治疗良性前列腺增生：希腊医疗机构的预算影响分析
3. Cost analysis of fixed-dose combination of dutasteride and tamsulosin compared with concomitant dutasteride and tamsulosin monotherapy in patients with benign prostatic hyperplasia in Canada [J] . Amyn Sayani, Afisi Ismaila, Anna Walker, Canadian Urological Association Journal . 2014,第1a2期

机译：固定剂量的度他雄胺和坦索罗辛与同期度他雄胺和坦索罗辛单药联合治疗在前列腺增生患者中的费用分析
4. Temperature Distribution in Prostate during Transurethral radio Frequency Thermotherapy Treatment of Benign Prostatic Hyperplasia [C] . ASME international mechanical engineering congressand exposition . 1999

机译：经尿道射频热疗治疗良性前列腺增生期间前列腺温度分布
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting [O] . Maria Geitona, Pinelopi Karabela, Ioannis A Katsoulis, 2014

机译：度他雄胺加坦索罗辛固定剂量联合一线治疗与坦索罗辛单药治疗良性前列腺增生：希腊医疗机构的预算影响分析
7. PIH12 Budget Impact Analysis of Adding a New Fixed-Dose Combination Therapy of Dutasteride and Tamsulosin to the Treatment of Symptomatic Benign Prostatic Hyperplasia in Quebec, Canada [O] . Ismaila A., Posnett J., Walker A., 2012

机译：PIH12预算影响分析，在加拿大魁北克增加了一种新的固定剂量联合应用度他雄胺和坦索罗辛治疗有症状的良性前列腺增生

Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting

著录项

相似文献

相关主题

期刊订阅